Hepatitis A vaccine, inactivated (GlaxoSmithKline)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHepatitis A vaccine, inactivated (GlaxoSmithKline)
Drug Alias Name灭活甲型肝炎疫苗（葛兰素史克）Havrix MonodoseHavrix JuniorHavrix
ClassificationVaccines > Development/production technology > Inactivated vaccine > Whole microorganism inactivated vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHepatitis ACytomegalovirus InfectionsHIV Infections +[5] 
Global Approved IndicationsHepatitis A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1995/02/22
Country/TerritoryUnited StatesPhilippinesFrance
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline PlcValneva Austria GmbhVirginia Commonwealth University
Active IndicationsHepatitis A
Inactive IndicationsCytomegalovirus InfectionsHIV InfectionsInfluenza, Human +[4] 

Other Information

ATC CodeJ07BC02
Related LinksN/A